Penumbra Interest Expense 2011-2026 | PEN

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Penumbra

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-682 K	1.01 M	-2.33 M	1.93 M	-343 K	-227 K	-504 K	-1.34 M	-1.84 M	-696 K	-309 K	-474 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.93 M	-2.33 M	-483 K

Quarterly Interest Expense Penumbra

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-535 K	812 K	445 K	1.28 M	-226 K	-366 K	-444 K	444 K	416 K	-	-2.36 M	-956 K	-1.01 M	-	-1.14 M	-408 K	-1.48 M	-	14 K	511 K	-1.66 M	-	-772 K	-71 K	24 K	-	170 K	-340 K	-290 K	-	-102 K	-214 K	-349 K	-	-360 K	-272 K	-224 K	-	-115 K	-542 K	44 K	-	-56 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.28 M	-2.36 M	-297 K

Interest Expense of other stocks in the Medical devices industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
AxoGen AXGN	-199 K	$ 33.22	1.87 %	$ 1.47 B	USA
Allied Healthcare Products AHPI	191 K	-	3.58 %	$ 2.21 M	USA
Apollo Endosurgery APEN	4.67 M	-	-	$ 475 M	USA
Axonics Modulation Technologies AXNX	-2.43 M	-	-	$ 3.31 B	USA
Acutus Medical AFIB	5.66 M	-	-26.83 %	$ 2.62 M	USA
Aziyo Biologics AZYO	5.8 M	-	1.37 %	$ 20.5 M	USA
Cognyte Software Ltd. CGNT	-1.61 M	$ 7.01	2.04 %	$ 503 M	Israel
Apyx Medical Corporation APYX	2.48 M	$ 3.76	-1.7 %	$ 130 M	USA
Alphatec Holdings ATEC	24.9 M	$ 13.29	1.41 %	$ 1.9 B	USA
BIOLASE BIOL	-1 K	-	-13.19 %	$ 166 K	USA
Bio-Rad Laboratories BIO	48.9 M	$ 255.19	-12.51 %	$ 7.2 B	USA
Conformis CFMS	2.02 M	-	-	$ 16.4 M	USA
Bruker Corporation BRKR	-38.2 M	$ 36.35	-3.09 %	$ 5.42 K	USA
BioSig Technologies BSGM	23 K	-	37.08 %	$ 85.7 M	USA
CONMED Corporation CNMD	37.3 M	$ 41.59	-0.28 %	$ 1.28 B	USA
Boston Scientific Corporation BSX	305 M	$ 74.77	0.88 %	$ 110 B	USA
Abbott Laboratories ABT	376 M	$ 112.22	0.66 %	$ 195 B	USA
Cardiovascular Systems CSII	1.63 M	-	0.15 %	$ 844 M	USA
EDAP TMS S.A. EDAP	232 K	$ 4.8	0.63 %	$ 179 M	France
Delcath Systems DCTH	-30 K	$ 9.25	1.43 %	$ 264 M	USA
Cutera CUTR	-244 K	-	-10.19 %	$ 1.99 M	USA
ClearPoint Neuro CLPT	-40 K	$ 13.44	3.07 %	$ 363 M	USA
Electromed ELMD	78 K	$ 24.2	3.82 %	$ 205 M	USA
Dynatronics Corporation DYNT	410 K	-	14.99 %	$ 929 K	USA
Neovasc NVCN	133 K	-	-	$ 111 M	Canada
Eargo EAR	549 K	-	-	$ 10.2 M	USA
Inogen INGN	850 K	$ 5.71	-1.38 %	$ 135 M	USA
IRadimed Corporation IRMD	164 K	$ 99.81	-0.03 %	$ 1.26 B	USA
Integer Holdings Corporation ITGR	-3.52 M	$ 85.46	0.23 %	$ 2.87 B	USA
Second Sight Medical Products EYES	1.19 M	-	-0.97 %	$ 54.4 M	USA
Avinger AVGR	1.72 M	-	-20.74 %	$ 369 K	USA
FONAR Corporation FONR	347 K	$ 18.55	0.05 %	$ 122 M	USA
Pulmonx Corporation LUNG	256 K	$ 1.47	3.17 %	$ 57.5 M	USA
Globus Medical GMED	2.2 M	$ 87.89	0.76 %	$ 11.9 B	USA
Integra LifeSciences Holdings Corporation IART	3.94 M	$ 11.29	4.46 %	$ 869 M	USA
Myomo MYO	21.1 K	$ 0.82	0.41 %	$ 5.78 M	USA
Establishment Labs Holdings ESTA	-15.3 M	$ 75.22	2.28 %	$ 2.12 B	Costa-rica